// App-Quantinova.ai

: USE OF INTRAVENOUS CANGRELOR/DAPT BRIDGE THERAPY FOR POST-PCI PATIENTS UNDERGOING GASTROINTESTINAL SURGERY

Researchers

Presenter

  • Abdul Ahad Khan

Principal Investigators

  • Thomas Helton

  • Terry Forrest

  • Ranae Ratkovec

Medical Centers

  • East Tennessee State University, Johnson City, TN

  • James H. Quillen Department of Veterans Affairs Medical Center, Mountain Home, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Gastroenterology (GU)

  • Pulmonary/Respiratory Diseases

Disease

  • Arrhythmia

  • Restenosis

  • Venous thrombosis

  • Gastrointestinal bleeding

Biomarkers

  • N/A

Drug/Treatment

  • Ticagrelor

  • cangrelor

  • apixaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved